Discover investment opportunities in Healthcare AI Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Healthcare AI Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Healthcare AI Stocks using our Smart AI Filter.
9 stocks found for "Healthcare AI Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.64 Risk measure | ±28.2% Price volatility | 69.3 Valuation | 0.00% Annual yield | |||
1.02 Risk measure | ±49.1% Price volatility | 40.9 Valuation | 0.00% Annual yield | |||
1.77 Risk measure | ±71.4% Price volatility | -18.6 Valuation | 0.00% Annual yield | |||
1.19 Risk measure | ±53.7% Price volatility | -156.9 Valuation | 0.00% Annual yield | |||
0.92 Risk measure | ±51.9% Price volatility | 41.3 Valuation | 0.00% Annual yield | |||
1.92 Risk measure | ±85.0% Price volatility | -11.8 Valuation | 0.00% Annual yield | |||
1.50 Risk measure | ±64.8% Price volatility | -8.0 Valuation | 0.00% Annual yield | |||
0.36 Risk measure | ±21.7% Price volatility | 15.1 Valuation | 3.17% Annual yield | |||
1.24 Risk measure | ±76.9% Price volatility | 51.8 Valuation | 0.00% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: What differentiates Intuitive Surgical, Inc. (ISRG) in the healthcare AI sector?
A: Intuitive Surgical is a leader in robotic-assisted surgery, offering the da Vinci system which enhances precision in minimally invasive surgery. Its technology leverages AI to improve surgical outcomes, giving it a competitive edge in healthcare robotics.
Q: Why might investors consider Teladoc Health, Inc. (TDOC) for growth potential?
A: Teladoc Health is a prominent player in telemedicine, expanding access to healthcare through AI-driven virtual care solutions. Its position as a telehealth leader suggests potential growth, driven by increasing demand for online medical consultations.
Q: How does Invitae Corporation (NVTA) utilize AI in its operations?
A: Invitae Corporation integrates AI with genetic testing to enhance the accuracy and efficiency of its diagnostics. This integration aims to make genetic information more accessible and valuable, positioning Invitae as a forward-looking player in personalized medicine.
Q: What are the investment risks associated with Clovis Oncology, Inc. (CLOV)?
A: Clovis Oncology faces risks typical of biotech firms, such as regulatory hurdles, R&D inefficacy, and capital intensity. The high volatility of biotech stocks, alongside its focus on cancer treatments, requires investors to consider pipeline success and market conditions closely.
Q: What role does AI play in the operations of Guardant Health, Inc. (GH)?
A: Guardant Health uses AI to analyze genomic data for cancer diagnostics and treatment monitoring. This enhances the detection and management of cancers, but investors should monitor regulatory developments and competition in the liquid biopsy space.
Q: How might Pacific Biosciences of California, Inc. (PACB) benefit from advancements in AI?
A: Pacific Biosciences employs AI in its DNA sequencing technology, aiming to deliver higher accuracy in reading complex genomic sequences. Advancements in AI could further improve sequencing accuracy and reduce costs, benefiting PACB's market position.
Besides Wall Street's top-and-bottom-line estimates for Intuitive Surgical (ISRG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
Read moreThe average of price targets set by Wall Street analysts indicates a potential upside of 26.2% in Exact Sciences (EXAS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Read more